Oral cholestyramine prevents enrichment of diverse daptomycin-resistance mutations in intestinal Enterococcus faecium
V. J. Morley, D. G. SIm, A. Penkevich, R. Woods, A. F. Read
This study shows that cholestyramine prevents the enrichment of daptomycin-resistant Enterococcus faecium mutations in the gut when administered before or after daptomycin treatment.
bioRxiv · May 25, 2022 · PreprintMicrobiology